Orbo, Anne <br/><br/>
Urinary cyclic GMP after treatment of gynecological cancer. A prognostic marker of clinical outcome.  [electronic resource] 

 -  Anticancer research   
 - 2591-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0250-7005 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Biomarkers, Tumor--blood<br/>CA-125 Antigen--blood<br/>Carcinoembryonic Antigen--blood<br/>Cyclic AMP--urine<br/>Cyclic GMP--urine<br/>Female<br/>Follow-Up Studies<br/>Genital Neoplasms, Female--blood<br/>Humans<br/>Middle Aged<br/>Neoplasm Recurrence, Local--blood<br/>Peptide Fragments--blood<br/>Procollagen--blood<br/>Prognosis<br/>Sensitivity and Specificity<br/>Treatment Outcome